Medfyle im Vergleich zu Center for Learning Nutzung und Statistiken

Medfyle® is an educational tool for physicians and health care professionals that distills cutting-edge science from the key medical journals and conferences into a simple, concise and user-friendly format, based on the concept of microlearning. The Medfyle summaries are created in collaboration with the world's top medical journals and leading professional societies, and are peer-reviewed by the Medfyle specialty editors. Each Medfyle summary also includes: an expert commentary (text and podcast), access to the original article or content, related content, downloadable summary slides, and many more learning opportunities. Medfyle is designed to provide the latest developments in a unique format that best suits your hectic daily schedules. Simple, Fast, Accurate, Reliable. The information you need, in the palm of your hand! Download the app for free now!
  • Apple App Store
  • Kostenlos
  • Bildung

Rang speichern

- -

Offered in a wide array of formats to meet your schedule and learning preferences, our EndoLearn mobile app offers trainings and education opportunities covering all areas of endocrinology, diabetes, and metabolism. Fully synchronized with Endocrine Society Center for Learning, EndoLearn provides a wealth of activities that offer American Board of Internal Medicine (ABIM) Medical Knowledge points or American Board of Pediatrics (ABP) MOC Part 2 points, all while keeping your learning on the go.
  • Apple App Store
  • Kostenlos
  • Bildung

Rang speichern

- -

Medfylevs. Center for Learning Ranking-Vergleich

Vergleichen Sie Medfyle den Ranking-Trend der letzten 28 Tage mit Center for Learning

Rang

Keine Daten verfügbar

Medfyle im Vergleich zu Center for Learning Ranking im Ländervergleich

Vergleichen Sie Medfyle den Ranking-Trend der letzten 28 Tage mit Center for Learning

Keine Daten zum Anzeigen

Stellen Sie mit unserer kostenlosen Testversion Vergleiche mit jeder Website an

Los geht's
Medfyle VS.
Center for Learning

Dezember 15, 2024